You are here

antibodies

Lilly-partnered AbCellera gets COVID-19 boost from Canadian government

Fierce Biotech

Mon, 05/4/20 - 10:56 am

FDA Grants Emergency Authorization To Roche Antibody Tests

Forbes

Sun, 05/3/20 - 08:07 pm

Emergency Use Authorization

A COVID-19 treatment inspired by llamas

Fierce Biotech

Thu, 04/30/20 - 10:16 pm

drug development

animal research

AbCellera and Lilly Slash Antibody Selection Time for COVID-19 With AI/Machine Learning

BioSpace

Tue, 04/28/20 - 11:43 pm

artificial intelligence

machine learning

Cloned Antibodies to COVID-19 Virus Show Promise for Therapy and Prevention

BioSpace

Sat, 04/25/20 - 11:41 pm

cloned antibodies

Roche develops new COVID-19 antibody test

Pharmaforum

Fri, 04/17/20 - 10:49 am

Celltrion plans July COVID-19 trial, advances 'super antibody'

Fierce Biotech

Mon, 04/13/20 - 11:02 am

clinical trials

FDA Cautions Antibody Test Developers Against Falsely Claiming Tests are Authorized

RAPS.org

Wed, 04/8/20 - 11:57 pm

AstraZeneca targets summer start for COVID-19 antibody trial

Fierce Biotech

Wed, 04/8/20 - 10:31 am

clinical trials

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

AP

Fri, 04/3/20 - 12:27 pm

A COVID-19 Immunity Test Is on the Way

Motley Fool

Wed, 03/25/20 - 11:50 pm

When might experimental drugs to treat Covid-19 be ready? A forecast

Stat

Tue, 03/24/20 - 10:53 am

drug development

Gilead Sciences

IGM Biosciences files for $100 Million IPO

CP Wire

Tue, 08/20/19 - 09:57 am

IGM Biosciences

Philogen who? A low profile but pharma-connected Italian-Swiss hybrid steps out with $68M for a final push over the PhIII finish line

Endpoints

Mon, 05/13/19 - 09:19 am

clinical trials

Regeneron bags Calixar tech to support antibody discovery effort

Fierce Biotech

Mon, 04/29/19 - 09:44 pm

antibody discovery

Novartis inks 10-target antibody discovery deal with AbCellera

Fierce Biotech

Thu, 02/14/19 - 09:45 am

Eli Lilly buys itself an antibody R&D platform from Tillman Gerngross’s Adimab

Endpoints

Wed, 07/19/17 - 09:28 am

Could Merck and Leap union be the one for Keytruda?

TheStreet.com

Sat, 06/24/17 - 09:28 am

Leap Therapeutics

esophagogastric cancer

Valerion develops antibody delivery method for Pompe disease therapy

Drug Delivery Business News

Sat, 03/4/17 - 01:56 pm

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

Forbes

Mon, 06/20/16 - 10:18 am

esophageal cancer

Pages